Skip to main content
Novacyt logo

Novacyt — Investor Relations & Filings

Ticker · ALNOV ISIN · FR0010397232 LEI · 213800BWAC2BF295EG28 PA Manufacturing
Open in API
Filings indexed 1,101 across all filing types
Latest filing 2024-09-20 Regulatory Filings
Country FR France
Listing PA ALNOV

About Novacyt

https://novacyt.com/

Novacyt is an international molecular diagnostics company that provides a broad portfolio of integrated technologies and services. The company's core activities include the design, development, manufacturing, and commercialization of in vitro and molecular diagnostic tests, with a specialization in real-time PCR (qPCR) kits and reagents. Novacyt's solutions are applied across various markets, including clinical diagnostics for human health, with a focus on infectious diseases and oncology, as well as animal health and food safety. The company also offers custom development services, contract manufacturing, and pharmaceutical research services such as whole genome sequencing.

Recent filings

Filing Released Lang Actions
Rule 19.6(c) confirmation of post-offer intentions
Regulatory Filings Classification · 99% confidence The document is identified by the 'RNS Number' header and contains boilerplate text referencing 'RNS, the news service of the London Stock Exchange' and compliance with FCA regulations. The content specifically discusses a confirmation required under Rule 19.6(c) of the City Code on Takeovers and Mergers regarding post-offer intentions following the acquisition of Yourgene Health plc. This type of mandatory, short-form regulatory update that doesn't fit into specific financial reporting categories (like 10-K, ER, or IR) is best classified as a general Regulatory Filing. Given the presence of the RNS identifier and the nature of the announcement (a compliance confirmation), RNS is the most appropriate code, although it is a specific type of regulatory announcement.
2024-09-20 English
Confirmation de la règle 19.6(c) relative aux déclarations d'intention post-offre faites en relation avec Yourgene Health plc (« Yourgene »)
Legal Proceedings Report Classification · 99% confidence The document discusses the confirmation of post-offer intentions related to a takeover bid involving Novacyt S.A. and Yourgene Health plc, specifically referencing compliance with Rule 19.6(c) of the UK's Takeover Code. This subject matter—a formal announcement regarding the conclusion or compliance phase of a takeover or merger activity—directly aligns with the definition of M&A Activity (TAR). The text is a formal announcement detailing compliance steps following a recommended takeover offer (concordat under Part 26 of the Companies Act 2006). It is not a general regulatory filing (RNS), an earnings release (ER), or a quarterly report (IR). It is specifically about the transaction process.
2024-09-20 French
Rule 19.6(c) confirmation in respect of post-offer intention statements made in relation to Yourgene Health plc (“Yourgene”)
M&A Activity Classification · 100% confidence The document explicitly references compliance with 'RULE 19.6(C) OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE")' regarding post-offer intention statements following a takeover (Novacyt's acquisition of Yourgene Health plc). This type of mandatory disclosure related to the conclusion of a takeover process, often involving the Takeover Panel, does not fit neatly into standard financial reporting categories like 10-K, ER, or IR. It is a specific regulatory announcement concerning the merger/takeover process outcome. While it relates to M&A activity (TAR), the specific nature of the Rule 19.6(c) confirmation is a regulatory compliance filing. Given the options, 'Regulatory Filings' (RNS) serves as the best general category for specific, non-standard regulatory compliance announcements that aren't covered by the other specific codes, although it is closely related to M&A. However, since the core subject is the conclusion of a takeover process, and there is no specific code for 'Takeover Compliance Report', RNS is the most appropriate fallback for a mandatory regulatory announcement.
2024-09-20 English
Launch of new website
Regulatory Filings Classification · 100% confidence The document is identified by the header "RNS Number : 3946E" and contains a brief announcement titled "Launch of new website". It is a short communication (5121 characters) that primarily informs the market about an operational update (new website) and directs investors to the site for required information (AIM Rule 26). The footer explicitly states, "This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange." This structure strongly suggests a general regulatory announcement or press release that doesn't fit a specific financial reporting category (like 10-K, ER, or IR). Given the options, the most appropriate classification for a general, non-specific regulatory announcement distributed via RNS is 'Regulatory Filings' (RNS), as it is not a Report Publication Announcement (RPA) which typically announces the release of a major report, but rather a standalone operational update distributed through the regulatory feed.
2024-09-17 English
Launch of new website
Regulatory Filings Classification · 100% confidence The document is very short (4071 characters) and its primary purpose, as indicated by the title '**RNS REACH**' and the content, is to announce a specific, non-financial corporate event: the 'Launch of new website'. It explicitly mentions that all information required by AIM Rule 26 is now available on the new site. This structure—a brief announcement about a corporate action or information availability, often using an RNS header—fits the definition of a general regulatory announcement that doesn't fit a specific financial report category. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory disclosure that is not a financial report, earnings release, or management discussion.
2024-09-17 English
Lancement du nouveau site web
Report Publication Announcement Classification · 99% confidence The document is titled "PORTÉE DE RNS" (RNS Scope/Announcement) and announces the launch of a new company website. It provides contact details, information about the company (Novacyt S.A.), and its business segments. The key indicator is the explicit mention of "RNS" at the top, which typically signifies a Regulatory News Service announcement. Since the content is a general corporate update (website launch) and not a specific financial report (like 10-K, ER, IR) or a specific corporate action (like DIV, CAP, DIRS), it fits best into the general regulatory announcement category, which is RNS, or potentially RPA if it were announcing the publication of a different report. Given the context of a general update disseminated via RNS, the most appropriate code is RNS, as it serves as a general regulatory filing/announcement.
2024-09-17 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.